TORONTO, Oct. 28 /PRNewswire/ - Thomas Wellner, President and CEO of Therapure BioPharma Inc. and Dr. Cameron Clokie, President and CEO of Induce Biologics Inc. today announced a development partnership utilizing an innovative approach to the production and manufacture of selected growth factors for stimulating bone regeneration. Such growth factors are critical tools used in regenerative medicine, with particular applications in the regeneration of the skeleton.
Therapure will apply its experience and knowledge in cell culture and in the design and development of scaled-up biologic manufacturing processes to advance the initial research and development conducted by Induce. The technology is a result of over 10 years of research and development by the founders of Induce in the areas of bone regeneration and the development of growth factor containing bone grafts.
"Induce's technology is a tremendous example of the creativity and innovation that exists in Ontario," said Thomas Wellner. "We are very pleased that they have chosen Therapure Biopharma as their partner for the further development of this important new technology and we look forward to working with them to bring this product to a global market."
"Our technology was invented in Canada", said Cameron Clokie, "and we are excited to have found a company in Ontario that is capable of working with us to further develop this technology. We are pleased that Therapure Biopharma is as eager as we are to make this technology available to patients world-wide."
About Therapure Biopharma:
Therapure Biopharma Inc. is an integrated biopharmaceutical company that develops, manufactures, purifies, and packages therapeutic proteins. Therapure Biopharma acquired its Canadian-built and conceived facility from Hemosol Corporation, a specialist in therapies derived from hemoglobin, a blood protein. Therapure Biopharma applies scientific, manufacturing, and downstream purification expertise with an intimate understanding of advanced biology, complex proteins, and regulatory processes to develop effective and innovative solutions to advance products from discovery to market.
For more information, please visit: www.therapurebio.com
About Induce Biologics Inc.:
Induce Biologics Inc was founded in 2008 to develop and commercialize technologies invented at the University of Toronto. Induce Biologics' goal is to utilize these technologies along with others being developed internally to create cost effective growth factor containing bone grafts for mammalian skeletal regeneration.
CONTACT: Media Contact: Thomas Wellner, President and CEO, Therapure
Biopharma Inc., (905) 286-6204, firstname.lastname@example.org